Evansbrook’s Thermo Fisher Scientific TMO Stock Holding History

Evansbrook’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-371	Closed	-$215K	–	124
2025 Q4	$215K	Buy	+371	New	+$210K	0.14%	108

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Evansbrook's TMO Position: Q1 2026 in Review

Evansbrook sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 371 shares — an estimated $215K sold.

Evansbrook first reported a position in TMO in Q4 2025 and held it in 1 quarter. The position peaked at $215K in Q4 2025. 2,610 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Evansbrook reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Evansbrook sold 371 Thermo Fisher Scientific shares in Q1 2026, an estimated $215K.
Evansbrook first reported a position in Thermo Fisher Scientific in Q4 2025 and held it in 1 quarter.
Evansbrook's Thermo Fisher Scientific position peaked at $215K in Q4 2025.
2,610 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Evansbrook's 13F filing for Q1 2026, filed 4 Jun 2026.